Bluefish Pharmaceuticals Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
139
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
12
- Investments
-
1
Bluefish Pharmaceuticals General Information
Description
Manufacturer of generic pharmaceutical products intended to make quality medicines accessible to more people. The company offers a product portfolio consisting of a broad range of generics for all major therapeutic areas and used in the treatment of diabetes, breast cancer, depression and anxiety disorders, migraine headaches, panic attacks and schizophrenia, thereby providing patients with safer pharmaceutical products at affordable prices.
Contact Information
Website
www.bluefishpharma.comCorporate Office
- Gävlegatan 22
- 113 30 Stockholm
- Sweden
Corporate Office
- Gävlegatan 22
- 113 30 Stockholm
- Sweden
Bluefish Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bluefish Pharmaceuticals Comparisons
Industry
Financing
Details
Bluefish Pharmaceuticals Competitors (36)
One of Bluefish Pharmaceuticals’s 36 competitors is MS Pharma, a Private Equity-Backed company based in Amman, Jordan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MS Pharma | Private Equity-Backed | Amman, Jordan | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Beximco Pharmaceuticals | Corporation | Dhaka, Bangladesh | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| The Zambon Group | Private Debt Financed | Bresso, Italy |
Bluefish Pharmaceuticals Signals
Bluefish Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bluefish Pharmaceuticals Investments (1)
Bluefish Pharmaceuticals’s most recent deal was a Buyout/LBO with BMM Pharma. The deal was made on 26-Aug-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BMM Pharma | 26-Aug-2011 | Buyout/LBO | Distributors (Healthcare) |
Bluefish Pharmaceuticals Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Bluefish Pharma France | Paris, France | 2010 | |
| BMM Pharma | Stockholm, Sweden | 2002 |
Bluefish Pharmaceuticals FAQs
-
When was Bluefish Pharmaceuticals founded?
Bluefish Pharmaceuticals was founded in 2005.
-
Where is Bluefish Pharmaceuticals headquartered?
Bluefish Pharmaceuticals is headquartered in Stockholm, Sweden.
-
What is the size of Bluefish Pharmaceuticals?
Bluefish Pharmaceuticals has 139 total employees.
-
What industry is Bluefish Pharmaceuticals in?
Bluefish Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Bluefish Pharmaceuticals a private or public company?
Bluefish Pharmaceuticals is a Private company.
-
What is Bluefish Pharmaceuticals’s current revenue?
The current revenue for Bluefish Pharmaceuticals is .
-
How much funding has Bluefish Pharmaceuticals raised over time?
Bluefish Pharmaceuticals has raised $30.2M.
-
Who are Bluefish Pharmaceuticals’s investors?
Färna Invest and Quesada Kapitalförvaltning have invested in Bluefish Pharmaceuticals.
-
Who are Bluefish Pharmaceuticals’s competitors?
MS Pharma, Pfizer (Vienna), Beximco Pharmaceuticals, Pfizer Pakistan, and The Zambon Group are some of the 36 competitors of Bluefish Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process